Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Mir-216 Is a Key Regulator and Potential Marker in Human Cancers Publisher

Summary: MicroRNA-216 could be a key biomarker in cancer, acting as both an oncogene and tumor suppressor across various cancers. Could it help in early diagnosis? #CancerResearch #Biomarkers

Mondeali M ; Mozaffari F ; Ghiasizadeh P ; Bakhti S ; Salehi M ; Kamali N ; Rafat M
Authors

Source: Advanced Biomedical Research Published:2025


Abstract

MicroRNAs, a class of small noncoding RNAs, have been identified as promising biomarkers for cancer identification and management by regulating gene expression and other cellular biological pathways. This review gathers findings for understanding the molecular basis and clinical importance of microRNA-216 (miR-216) in several cancers. Increased or decreased expression of miR-216 has been observed in a variety of cancers, including esophageal cancer, breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, cervical cancer, brain tumor (glioma), prostate cancer, and acute myeloid leukemia, indicating its activity as an oncogene or tumor suppressor. Through this study, we proposed that miR-216 can potentially be a candidate as a prognostic marker for early detection of tumor development, progression, as well as metastasis in cancer patients. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
7. Spotlight on the Expanding Role of Mir-647 in Human Cancers, Advanced Biomedical Research (2023)
10. The Prominent Role of Mir-942 in Carcinogenesis of Tumors, Advanced Biomedical Research (2022)
19. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)